Latest:
Dr. Kazmi Discusses Olanzapine for Breakthrough CINV
Dr. Shayma Kazmi, from Cancer Treatment Centers of America, on Olanzapine for Breakthrough Chemotherapy-Induced Nausea and Vomiting
Authors
Shereen Stutz, RPH
Latest:
The FDA Could Help Address Financial Toxicity During the Approval Process
Given the widespread financial impact the high cost of cancer drugs has on the healthcare system, it may be time for the FDA to take a broader approach when reviewing oncology drug applications. By also examining the cost of the drug, the FDA could shine a light on escalating drug costs and play a leadership role in creating new programs and initiatives that help patients pay for promising new therapies.
Sheri Holmen, PhD
Latest:
Sheri Holmen on Understanding Drivers of Melanoma Metastasis
Sheri Holmen, PhD, investigator, Associate Professor in the Department of Surgery, Adjunct Professor in the Department of Oncological Sciences, Huntsman Cancer Institute, the University of Utah School of Medicine, discusses understanding drivers for melanoma metastasis.
Shin Yin Lee, MD
Latest:
Geriatric Oncology: Learning the Balancing Act of Treating the Older Cancer Patient
Whether it be to identify a seemingly frail older patient
with metastatic colon cancer who would tolerate
and benefit from standard treatment, or to prevent a
frail older lung cancer patient from experiencing severe
side effects due to adjuvant chemotherapy, oncologists
are having to make difficult decisions with increasing
frequency.
Shirish Gadgeel, MD
Latest:
Leveraging ctDNA Platforms in High-Risk Patients: Current Applications and Future Potential
Panelists discuss how they currently utilize emerging ctDNA platforms for high-risk patients and explore whether these advancements will soon become standard practice in clinical decision-making.
Shirish M. Gadgeel, MD, MBBS
Latest:
Dr. Gadgeel on the Utility of Liquid Biopsies in Lung Cancer
Shirish M. Gadgeel, MD, MBBS, Mary Lou Kennedy Research Professor in Thoracic Oncology, professor, Department of Internal Medicine, Division of Hematology/Oncology, co-leader, Thoracic Oncology Research Program, and associate director, Networking and Affiliated Centers, University of Michigan Medicine, discusses the utility of liquid biopsies in lung cancer.